Substituted 1,3-thiazole compounds, their production and use
    3.
    发明授权
    Substituted 1,3-thiazole compounds, their production and use 失效
    取代的1,3-噻唑化合物,其生产和使用

    公开(公告)号:US07495018B2

    公开(公告)日:2009-02-24

    申请号:US10239692

    申请日:2001-03-29

    IPC分类号: A61K31/4436 C07D417/04

    CPC分类号: C07D417/04

    摘要: (1) A 1,3-thiazole compound of which the 5-position is substituted with a 4-pyridyl group having a substituent including no aromatic group or (2) a 1,3-thiazole compound of which the 5-position is substituted with a pyridyl group having at the position adjacent to a nitrogen atom of the pyridyl group a substituent including no aromatic group has an excellent p38 MAP kinase inhibitory activity.

    摘要翻译: (1)5-取代的不具有芳香族基团的取代基的4-吡啶基的1,3-噻唑化合物或(2)取代有5位的1,3-噻唑化合物 在与吡啶基的氮原子相邻的位置具有吡啶基的情况下,不含芳香族基团的取代基具有优异的p38MAP激酶抑制活性。

    5-pyridyl-1, 3-azole compounds, process for producing the same and use there of
    4.
    发明申请
    5-pyridyl-1, 3-azole compounds, process for producing the same and use there of 审中-公开
    5-吡啶基-1,3-唑化合物,其制备方法和用途

    公开(公告)号:US20090048307A1

    公开(公告)日:2009-02-19

    申请号:US11896072

    申请日:2007-08-29

    CPC分类号: C07D417/14 C07D417/04

    摘要: An optionally N-oxidized compound represented by the formula: wherein R1 represents hydrogen, hydrocarbon, heterocycle, amino, acyl, R2 represents an aromatic group, R3 represents hydrogen, pyridyl, aromatic hydrocarbon, X represents oxygen, optionally oxidized sulfur, Y represents a bond, an oxygen, optionally oxidized sulfur, a group represented by the formula NR4 (R4 represents hydrogen, hydrocarbon or acyl) and Z represents a bond or a divalent acyclic hydrocarbon, or a salt thereof has an excellent adenosine A3 receptor antagonistic activity and is used as an agent for preventing or treating diseases related to an adenosine A3 receptor. Furthermore, the compound (I) or a salt thereof has p38 MAP kinase inhibitory activity and TNF-α inhibitory activity and is used as an agent for preventing or treating diseases related to p38 MAP kinase and diseases related to TNF-α.

    摘要翻译: 由下式表示的任选的N-氧化化合物:其中R1表示氢,烃,杂环,氨基,酰基,R2表示芳族基团,R3表示氢,吡啶基,芳香烃,X表示氧,任选氧化的硫,Y表示 键,氧,任选氧化的硫,由式NR4表示的基团(R4表示氢,烃或酰基),Z表示键或二价无环烃或其盐具有优异的腺苷A3受体拮抗活性,并且为 用作预防或治疗与腺苷A3受体有关的疾病的药剂。 此外,化合物(I)或其盐具有p38 MAP激酶抑制活性和TNF-α抑制活性,并且用作预防或治疗与p38 MAP激酶相关的疾病和与TNF-α相关的疾病的药剂。

    5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
    6.
    发明授权
    5-pyridyl-1,3-azole compounds, process for producing the same and use thereof 失效
    5-吡啶基-1,3-唑化合物,其制备方法及其用途

    公开(公告)号:US07276527B2

    公开(公告)日:2007-10-02

    申请号:US11354897

    申请日:2006-02-16

    IPC分类号: A61K31/4436 C07D417/04

    CPC分类号: C07D417/14 C07D417/04

    摘要: An optionally N-oxidized compound represented by the formula: wherein R1 represents hydrogen, hydrocarbon, heterocycle, amino, acyl, R2 represents an aromatic group, R3 represents hydrogen, pyridyl, aromatic hydrocarbon, X represents oxygen, optionally oxidized sulfur, Y represents a bond, an oxygen, optionally oxidized sulfur, a group represented by the formula NR4 (R4 represents hydrogen, hydrocarbon or acyl) and Z represents a bond or a divalent acyclic hydrocarbon, or a salt thereof has an excellent adenosine A3 receptor antagonistic activity and is used as an agent for preventing or treating diseases related to an adenosine A3 receptor. Furthermore, the compound (I) or a salt thereof has p38 MAP kinase inhibitory activity and TNF-α inhibitory activity and is used as an agent for preventing or treating diseases related to p38 MAP kinase and diseases related to TNF-α.

    摘要翻译: 由下式表示的任选的N-氧化化合物:其中R 1表示氢,烃,杂环,氨基,酰基,R 2表示芳族基团, 3表示氢,吡啶基,芳香烃,X表示氧,任选氧化的硫,Y表示键,氧,任选氧化的硫,由式NR 4表示的基团(R 4代表氢,烃或酰基),Z表示键或二价无环烃,或其盐具有优异的腺苷A 3受体拮抗活性,并用作 用于预防或治疗与腺苷A 3受体相关的疾病的药剂。 此外,化合物(I)或其盐具有p38 MAP激酶抑制活性和TNF-α抑制活性,并且用作预防或治疗与p38 MAP激酶相关的疾病和与TNF-α相关的疾病的药剂。

    5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
    7.
    发明申请
    5-pyridyl-1,3-azole compounds, process for producing the same and use thereof 失效
    5-吡啶基-1,3-唑化合物,其制备方法及其用途

    公开(公告)号:US20060135566A1

    公开(公告)日:2006-06-22

    申请号:US11354897

    申请日:2006-02-16

    CPC分类号: C07D417/14 C07D417/04

    摘要: An optionally N-oxidized compound represented by the formula: wherein R1 represents hydrogen, hydrocarbon, heterocycle, amino, acyl, R2 represents an aromatic group, R3 represents hydrogen, pyridyl, aromatic hydrocarbon, X represents oxygen, optionally oxidized sulfur, Y represents a bond, an oxygen, optionally oxidized sulfur, a group represented by the formula NR4 (R4 represents hydrogen, hydrocarbon or acyl) and Z represents a bond or a divalent acyclic hydrocarbon, or a salt thereof has an excellent adenosine A3 receptor antagonistic activity and is used as an agent for preventing or treating diseases related to an adenosine A3 receptor. Furthermore, the compound (I) or a salt thereof has p38 MAP kinase inhibitory activity and TNF-α inhibitory activity and is used as an agent for preventing or treating diseases related to p38 MAP kinase and diseases related to TNF-α.

    摘要翻译: 由下式表示的任选的N-氧化化合物:其中R 1表示氢,烃,杂环,氨基,酰基,R 2表示芳族基团, 3表示氢,吡啶基,芳香烃,X表示氧,任选氧化的硫,Y表示键,氧,任选氧化的硫,由式NR 4表示的基团(R 4代表氢,烃或酰基),Z表示键或二价无环烃,或其盐具有优异的腺苷A 3受体拮抗活性,并用作 用于预防或治疗与腺苷A 3受体相关的疾病的药剂。 此外,化合物(I)或其盐具有p38 MAP激酶抑制活性和TNF-α抑制活性,并且用作预防或治疗与p38 MAP激酶相关的疾病和与TNF-α相关的疾病的药剂。

    5-pyridyl-1,3-azole compounds, process for producing the same and use thereof

    公开(公告)号:US07101899B1

    公开(公告)日:2006-09-05

    申请号:US09959356

    申请日:2000-04-20

    IPC分类号: A61K31/445 C07D417/04

    CPC分类号: C07D417/14 C07D417/04

    摘要: An optionally N-oxidized compound represented by the formula: wherein R1 represents hydrogen, hydrocarbon, heterocycle, amino, acyl, R2 represents an aromatic group, R3 represents hydrogen, pyridyl, aromatic hydrocarbon, X represents oxygen, optionally oxidized sulfur, Y represents a bond, an oxygen, optionally oxidized sulfur, a group represented by the formula NR4 (R4 represents hydrogen, hydrocarbon or acyl) and Z represents a bond or a divalent acyclic hydrocarbon, or a salt thereof has an excellent adenosine A3 receptor antagonistic activity and is used as an agent for preventing or treating diseases related to an adenosine A3 receptor. Furthermore, the compound (I) or a salt thereof has p38 MAP kinase inhibitory activity and TNF-α inhibitory activity and is used as an agent for preventing or treating diseases related to p38 MAP kinase and diseases related to TNF-α.